Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?

Archives of Gynecology and Obstetrics

Volumn 283, Issue 6, 2011, Pages 1313-1318

  El Shennawy, Gehan A ^a   Elbialy, Abd Alla A ^a   Isamil, Anwar E ^b   El Behery, Manal M ^b  

^a Zagazig University   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

CYP1A1; ER ; Polymorphism; Uterine myoma

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DNA; ESTROGEN RECEPTOR ALPHA; ISOLEUCINE; LEUCINE; VALINE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA SEQUENCE; EGYPT; EXON; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; UTERUS MYOMA;

ADULT; ALLELES; ARYL HYDROCARBON HYDROXYLASES; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; EGYPT; ESTROGEN RECEPTOR ALPHA; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; LEIOMYOMA; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; UTERINE NEOPLASMS;

EID: 79956126948     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-010-1550-x     Document Type: Article

References (22)

1. Parker WH (2007) Etiology, symptomatology and diagnosis of uterine myomas. Fertil Steril 87:725-736
2. Haney AF (2000) Clinical decision making regarding leiomyomata: what we need in the next millennium. Environ Health Perspect 108(Suppl 5):835-839
3. Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100-107 (Pubitemid 36135604)
4. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, Gilbert M, Hamann U, Scott RJ (2010) Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk. Cancer Epidemiol [Epub ahead of print]
5. Jakimiuk AJ, Bogusiewiez M, Tarkowski R, Dziduch P et al (2004) Estrogen receptor alpha and beta expression in uterine leiomyomas from premenopausal women. Fertil Steril 82:1244-1249 (Pubitemid 39335945)
6. Shastry BS (2002) SNP alleles in human disease and evolution. J Hum Genet 47(11):561-566
7. Ye Yi, Cheng Xiao, Hai-Boluo Li, Liu Ying-Bi, Li Yi-Ping (2008) CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. J Assist Reprod Genet 25:389-394
8. Zhou XJ, Cen XJ, Lu DR (2004) Distribution of the CYP1A1 polymorphisms in shanghai population. J Kunming Teach Coll 26:53-58
9. Aklillu E, Dverbo S, Botnen IV, Otter C, Ingelman-Sundberg M (2005) Characterization of common CYP1B1 variants with different capacity for benzo(a)pyrene-7,8-dihydrodiol epoxide formation from benzo(a)pyrene. Cancer Res 65:5105-5111 (Pubitemid 40827319)
10. Dupont W, Plummer W (1997) PS power and sample size program available for free on the internet. Control Clin Trials 18:274
11. Massart F, Becherinil L, Marini F et al (2003) Analysis of estrogen receptor (ERα and ERβ) and progesterone receptor (PR) polymorphisms in uterine leiomyomas. Med Sci Monit 9(1):25-30
12. Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA, Zhu BT (1995) 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci USA 92:9220-9224
13. Zhai X-D, Ye Y, Yang Y, Wang Z, Mo Y-N (2009) No association between estrogen receptor beta polymorphisms and uterine leiomyoma. DNA Cell Biol 28(12):633-636
14. Hsieh YY, Wang YK, Chang CC, Lin CS (2007) Estrogen receptor (alpha)-351 x bal* G and -397 Pvull, *C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Mol Hum Reprod 13(2):117-122
15. Newbold RR, Liehr JG (2000) Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 60:235-237 (Pubitemid 30070740)
16. Herr S, Bettenorf H, Denschlag D, Keck C, Pietrowski D (2006) Cytochrome P2A13 and P1A1 gene polymorphism are associated with the occurence of uterine leiomyoma. Arch Gynecol Obstet 247:0201-0208
17. Boyapati SM, Shu XO, Gao YT, Cai Q, Jin F, Zheng W (2005) Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case control study of Chinese women. Cancer 103:2228-2235 (Pubitemid 40686565)
18. Sillanpaa P, Heikinheimo L, Kataja V, Eskelinen L et al (2007) CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population. Breast Cancer Res Treat 104:287-297 (Pubitemid 47231273)
19. Meyer UA, Gut J, Kronbach T, Skoda C, Meier UT, Catin T (1986) The molecular mechanisms of two common polymorphisms of drug oxidation*/ evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. Xenobiotica 16:449-464 (Pubitemid 16076723)
20. Gaudet MM, Chanoch S, Lissowska J, Berndt SI, Yang XR, Peplonska B et al (2006) Genetic variation of cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among polish women. Pharmacogenet Genomics 16:547-553 (Pubitemid 44100199)
21. Paracchini V, Raimondi S, Gram LI, Kang D, Cocabas NA, Kristensen NV et al (2007) Meta-and pooled analyses of the cytochrome P-450 1B1val 432 leu polymorphism and breast cancer: a HuGE-GSEC review. Am J Epidemiol 165:115-125 (Pubitemid 46096372)
22. Cho YJ, Hur SE, Lee JY, Song IO, Moon HS, Koong MK et al (2007) Single nucleotide polymorphisms and haplotypes of the genes encoding the CYP1B1 in Korean women: no association with advanced endometriosis. J Assist Reprod Genet 24:271-277 (Pubitemid 47593595)